cilengitide has been researched along with Lymphoma, T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, H; Amorós, M; Bolontrade, M; Cayrol, F; Cerchietti, L; Cremaschi, GA; Díaz Flaqué, MC; Farías, RN; Fernando, T; Inghirami, G; Isse, B; Singh, A; Sterle, HA; Tabbò, F; Tian, YF; Yang, SN | 1 |
1 other study(ies) available for cilengitide and Lymphoma, T-Cell
Article | Year |
---|---|
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Integrin alphaVbeta3; Jurkat Cells; Lymphoma, T-Cell; Male; Mice; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; RNA, Small Interfering; Signal Transduction; Snake Venoms; T-Lymphocytes; Thyroid Hormones; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2015 |